HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].

Abstract
Sixty-two patients with generalized anxiety disorder (GAD) and neurasthenia were studied. The effect of selank (30 patients) was compared to that of medazepam (32 patients). Patient's state was assessed with psychometric scales (Hamilton, Zung, CGI). Enkephalin activity in the blood serum was measured as well. The anxiolytic effects of both drugs were similar but selank had also antiasthenic and psychostimulant effects. The clinical-biological study revealed that patients with GAD and neurasthenia had the decreased level of tau(1/2) leu-enkephalin which was correlated with disease duration, severity of symptoms related to anxiety and asthenia and autonomic disorders. The increase of this parameter and stronger positive correlations with anxiety level were observed during the treatment with selank mostly in patients with GAD.
AuthorsA A Zozulia, G G Neznamov, T S Siuniakov, N V Kost, M V Gabaeva, O Iu Sokolov, E V Serebriakova, O A Siranchieva, A V Andriushenko, E S Telesheva, S A Siuniakov, A B Smulevich, N F Miasoedov, S B Seredenin
JournalZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (Zh Nevrol Psikhiatr Im S S Korsakova) Vol. 108 Issue 4 Pg. 38-48 ( 2008) ISSN: 1997-7298 [Print] Russia (Federation)
PMID18454096 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Anxiety Agents
  • Biomarkers
  • Enkephalins
  • Oligopeptides
  • Medazepam
  • TP 7
Topics
  • Administration, Intranasal
  • Administration, Oral
  • Adolescent
  • Adult
  • Anti-Anxiety Agents (administration & dosage, pharmacokinetics)
  • Anxiety Disorders (blood, drug therapy, psychology)
  • Biomarkers (blood)
  • Dose-Response Relationship, Drug
  • Enkephalins (blood)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Medazepam (administration & dosage, pharmacokinetics)
  • Middle Aged
  • Neurasthenia (blood, drug therapy, psychology)
  • Oligopeptides (administration & dosage, pharmacokinetics)
  • Psychometrics (methods)
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: